Trospium Chloride

曲司氯铵

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrospium Chloride
Drug Alias NameChlorure de trospium曲司氯胺托司氯铵Cloruro de trospioTrospii chloridum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsUrinary Bladder, OveractivePulmonary Disease, Chronic Obstructive
Global Approved IndicationsUrinary Bladder, Overactive
Approved Indications in ChinaUrinary Bladder, Overactive
Original Approved Country/TerritoryFrance
Original Approved Date1999/06/28
Country/TerritoryUnited StatesFranceMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesAllergan PlcMadaus Holding AgOdyssey Pharmaceuticals, Inc +[4] 
Inactive CompaniesEndo Pharmaceuticals Inc
Active IndicationsUrinary Bladder, Overactive
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeG04BD09
Related LinksWikipediaDrugBankKEGG